Integrated Extreme Real-Time PCR and High-Speed Melting Analysis in 52 to 87 Seconds

Clinical Chemistry: Journal of the American Association for Clinical Chemists

Sean J. Ison^1¹  Joseph T. Myrick^1²  Robert A. Palais^2,3³  Robert J. Pryor^2⁴ 

[1]Canon US Life Sciences, Inc., Rockville, MD.^4

[2]Canon Virginia, Inc., Newport News, VA^1

[3]Department of Mathematics, Utah Valley University, Orem, UT^3

[4]Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT^2

DOI  :  10.1373/clinchem.2018.296608

学科分类：过敏症与临床免疫学

来源: American Association for Clinical Chemistry

【 摘 要 】

BACKGROUND: Extreme PCR in <30 s and high-speed melting of PCR products in <5 s are recent advances in the turnaround time of DNA analysis. Previously, these steps had been performed on different specialized instruments. Integration of both extreme PCR and high-speed melting with real-time fluorescence monitoring for detection and genotyping is presented here. METHODS: A microfluidic platform was enhanced for speed using cycle times as fast as 1.05 s between 66.4 °C and 93.7 °C, with end point melting rates of 8 °C/s. Primer and polymerase concentrations were increased to allow short cycle times. Synthetic sequences were used to amplify fragments of hepatitis B virus (70 bp) and Clostridium difficile (83 bp) by real-time PCR and high-speed melting on the same instrument. A blinded genotyping study of 30 human genomic samples at F2 c.*97, F5 c.1601, MTHFR c.665, and MTHFR c.1286 was also performed. RESULTS: Standard rapid-cycle PCR chemistry did not produce any product when total cycling times were reduced to <1 min. However, efficient amplification was possible with increased primer (5 μmol/L) and polymerase (0.45 U/μL) concentrations. Infectious targets were amplified and identified in 52 to 71 s. Real-time PCR and genotyping of single-nucleotide variants from human DNA was achieved in 75 to 87 s and was 100% concordant to known genotypes. CONCLUSIONS: Extreme PCR with high-speed melting can be performed in about 1 min. The integration of extreme PCR and high-speed melting shows that future molecular assays at the point of care for identification, quantification, and variant typing are feasible.

【 授权许可】

All Rights reserved